To increase the availability of personal protective equipment (PPE) and other medical devices amid the coronavirus disease (COVID-19) pandemic, the US FDA this week eased import requirements for certain products. Typically, companies importing FDA-regulated products are required to submit entry information to the agency for the products. However, to ease burdens on importers and speed up the entry process for PPE and certain devices intended for emergency use or covered by an enforcement discretion policy, FDA is reducing the amount of information that needs to be submitted. Learn More